Cargando…
Deubiquitinase UCHL5 is elevated and associated with a poor clinical outcome in lung adenocarcinoma (LUAD)
Lung cancer is one of the most common malignant tumors in the world, with a high rate of malignancy and mortality. Seeking new biomarkers and potential drug targets is urgent for effective treatment of the disease. Deubiquitinase UCHL5/UCH37, as an important component of the 26S proteasome, plays cr...
Autores principales: | Zhang, Jieru, Xu, Hui, Yang, Xiaomei, Zhao, Yuanjie, Xu, Xinchun, Zhang, Ling, Xuan, Xiaofeng, Ma, Chunping, Qian, Wenxia, Li, Dawei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545677/ https://www.ncbi.nlm.nih.gov/pubmed/33046988 http://dx.doi.org/10.7150/jca.46146 |
Ejemplares similares
-
Upregulation of deubiquitinase PSMD14 in lung adenocarcinoma (LUAD) and its prognostic significance
por: Zhang, Ling, et al.
Publicado: (2020) -
STAMBP promotes lung adenocarcinoma metastasis by regulating the EGFR/MAPK signaling pathway
por: Xu, Hui, et al.
Publicado: (2021) -
Structural basis for specific inhibition of the deubiquitinase UCHL1
por: Grethe, Christian, et al.
Publicado: (2022) -
PSMD7 downregulation suppresses lung cancer progression by regulating the p53 pathway
por: Xu, Xinchun, et al.
Publicado: (2021) -
The deubiquitinase UCHL1 negatively controls osteoclastogenesis by regulating TAZ/NFATC1 signalling
por: Feng, Zhenhua, et al.
Publicado: (2023)